We make software for people who make things.
If you’ve ever driven a high-performance car, admired a towering skyscraper, used a smartphone, or watched a great film, chances are you’ve experienced what millions of Autodesk customers are doing with our software. With Autodesk, you have the power to make anything.
Learn more at autodesk.com.
Lydall creates a cleaner, safer and quieter world as one of the world’s leading manufacturers of specialty filtration solutions with highly engineered applications. Founded and headquartered in Manchester, Connecticut – an early American industrial hub for paper, lumber and textile production – Lydall has a truly global footprint, with more than 3,000 employees around the world and facilities across the United States, Canada, Europe and Asia-Pacific.
Partnering with our customers, we develop bespoke, high-performing and efficient solutions that are adaptable and scalable to meet their needs. We draw on our 150-year history of technical innovation, our deeply ingrained relationships with suppliers, and our state-of-the-art equipment to create critical and life-saving products.
Lydall is a New York Stock Exchange-listed company, trading under the ticker “LDL.”
3M applies science in collaborative ways to improve lives daily. With $32 billion in sales, the company’s 96,000 employees connect with customers all around the world. 3M invests about 6 percent of its sales into research and development – an investment that helps produce more than 3,000 patents each year. 3M owns 51 technology platforms, which range from adhesives and abrasives, to ceramics and nanotechnology. 3M's more than 8,500 scientists around the world share and combine these technologies across all its businesses to create a steady stream of unique products for customers.
3M is helping the world respond to COVID-19 at a time when the pandemic has created unprecedented demand for critical products. During this global crisis, the safety of our employees and the public, including health care workers and first responders fighting COVID-19, is our highest priority. We are making more respirators than ever before. Since January, we have doubled global N95 respirator production and are on track to increase our capacity to produce N95 and other respirators to 2 billion per year globally by the end of 2020.